Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment-Reference-Cited by-同舟云学术

Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment

Published:2015-03-24 Issue:12 Volume:6 Page:10548-10562
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ip Laura R. H.¹,Poulogiannis George²,Viciano Felipe Cia¹³,Sasaki Junko⁴,Kofuji Satoshi⁴,Spanswick Victoria J.⁵,Hochhauser Daniel⁵,Hartley John A.⁵,Sasaki Takehiko⁴,Gewinner Christina A.¹

Affiliation:

1. Department of Cancer Biology, UCL Cancer Institute, University College London, London, UK

2. The Institute of Cancer Research, Signalling and Cancer Metabolism, London, UK

3. Faculty of Infectious and Tropical Diseases, Immunology and Infection Department, London School of Hygiene & Tropical Diseases, London, UK

4. Department of Medical Biology, Akita University School of Medicine, Akita, Japan

5. Cancer Research UK Drug-DNA Interaction Research Group, UCL Cancer Institute, University College London, London, UK

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors;Gynecologic Oncology;2024-08

2. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib;Biochemical Pharmacology;2024-08

3. A spatial proteomic study of platinum refractory HGSOC implicates dual AKT and WNT activity linked to an immunosuppressive tumor microenvironment;Gynecologic Oncology;2024-06

4. Role of inositol polyphosphate-4-phosphatase type II in oncogenesis of digestive system tumors;World Journal of Gastrointestinal Oncology;2023-10-15

5. Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer;Cell Death & Disease;2022-10-28